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LDL plays an important role in atherosclerotic plaque formation and macrophage differentiation. However, there is no report
regarding the oxidation degree of LDL and macrophage differentiation. Our study has shown that the differentiation into M1 or
M2 macrophages is related to the lipid oxidation level of LDL. Based on the level of lipid peroxidation, LDL is classified into high-
oxidized LDL (hi-oxLDL) and low-oxidized LDL (low-oxLDL). The differentiation profiles of macrophages were determined by
surface receptor expression and cytokine secretion profiles. Low-oxLDL induced CD86 expression and production of TNF-𝛼 and
IL-12p40 in THP-1 cells, indicating anM1macrophage phenotype.Hi-oxLDL inducedmannose receptor expression and production
of IL-6 and monocyte chemoattractant protein-1, which mostly match the phenotype of M2 macrophages. Further supporting
evidence for an M2 polarization by hi-oxLDL was the induction of LOX-1 in THP-1 cells treated with hi-oxLDL but not with
low-oxLDL. Similar results were obtained in primary human monocytes. Therefore, our results strongly suggest that the oxidation
degree of LDL influences the differentiation of monocytes into M1 or M2 macrophages and determines the inflammatory fate in
early stages of atherosclerosis.
1. Introduction
Oxidized low-density lipoprotein (oxLDL) plays a critical
role in atherosclerotic plaque formation, which is triggered
by the persistence of lipid-laden macrophages [1] as well
as interfering endothelial cell motility [2] in arterial wall.
The differentiation of monocytes into macrophages, which
accumulate oxLDL to form foam cells, is induced by oxLDL
[1, 3]. The process starts with endothelial activation in the
subendothelial areas by oxLDL deposition [4, 5]. Monocytes
migrate into the intima guided by chemokines [6] and
differentiate into macrophages.These macrophages then take
up modified lipoproteins and, as they accumulate excess
lipids, they form foam cells [3].The foam cells die and release
intracellular contents [7], which induce an inflammatory
reaction. This in turn attracts more macrophages into the
lesion.During this process, LDLmay be oxidized by enzymes,
for example, myeloperoxidase [8, 9], or by reactive oxygen
species (ROS) [3] in the inflammatory microenvironment of
the plaque. Although oxLDL is important for atherosclerotic
inflammation, there is no report about the oxidation degree
of LDL and macrophage differentiation.
Macrophages are fundamental contributors in the devel-
opment and progression of atherosclerosis. Monocytes that
are recruited into the intima are exposed to a variety of
stimuli, such as cytokines, lipids, iron, and calcium, which
exist in complex microenvironments. These factors can
influence the phenotypic polarization of macrophages and
their subsequent activation [10]. Classically activated (M1)
macrophages and alternatively activated (M2) macrophages
are well-defined phenotypes. In addition, recent studies
suggested that several subtypes of M2 macrophages (M2a, b,
c, and d) and stimuli-induced subpopulations such as Mox,
Mhem,M (Hb), andM4macrophages exist in atherosclerotic
lesions [11].
Therefore, we hypothesized that LDL with different oxi-
dation levels exists in the early atherosclerotic milieu and
that the oxidation degree of LDL influences macrophage
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differentiation into classically activated (M1) or alternatively
activated (M2) macrophages, which determines the inflam-
matory fate for atherosclerotic development. In this study,
monocytes were treated with high-oxidized LDL (hi-oxLDL)
or low-oxidized LDL (low-oxLDL) and their surface receptor
expression and cytokine secretion profiles were analyzed to
determine if they differentiated into M1 or M2 macrophages.
2. Materials and Methods
2.1. Reagents. Human native LDL and oxidized LDL were
purchased from Biomedical Technologies Inc. (Stoughton,
MA, USA). During electrophoresis, low-oxLDL migrates
further than the native LDL and is also defined by a low
TBAR value (8.7–11.8 nmol/mg protein). Hi-oxLDL migrates
2.7 fold further than the native LDL and is defined by a
high TBAR value (55.7–75.6 nmol/mg protein). Anti-human
CD86-PE and anti-human CD206- (mannose receptor-)
FITC antibodies were purchased from Beckman Coulter
Inc. (Brea, CA, USA) and BD Biosciences (San Jose, CA,
USA), respectively. Anti-LOX-1 and anti-tubulin antibodies
were purchased from Abcam (Cambridge, MA, USA) and
BioLegend (San Diego, CA, USA), respectively. Recombinant
human M-CSF was purchased from BioLegend (San Diego,
CA, USA). LPS (E. coli O26:B6) was purchased from Sigma-
Aldrich (St. Louis, MO, USA).
2.2. Culture of THP-1 Cells. Thehumanmonocytic THP-1 cell
line was purchased from ATCC and cultured in RPMI1640
medium containing 10% FBS and penicillin-streptomycin
(100 units/mL and 100 𝜇g/mL, resp.) at 37∘C in a humidified
5% CO
2
incubator.
2.3. Analysis of Cell Proliferation. The cell proliferation rate
was measured using the colorimetric cell counting kit-8
(CCK-8) (Dojindo laboratories, Kyoto, Japan). THP-1 cells
were cultured at 1 × 105 cells per well in 24-well plates and
treated with native LDL, low-oxLDL, or hi-oxLDL (50 𝜇g/mL
each). After 24, 48, or 96 h, the CCK-8 reagent was added to
each well and cells were incubated for 30min at 37∘C. The
supernatant was harvested and transferred to 96-well plates.
The O.D. at 450 nm was determined with a spectrophotome-
ter.
2.4. Flow Cytometry. THP-1 cells were cultured at 2 × 105
cells per well in 12-well plates and treated with native LDL,
low-oxLDL, or hi-oxLDL (50 𝜇g/mL each). After 24 or 96 h,
cells were harvested and analyzed using flow cytometry to
measure granularity and autofluorescence. To detect surface
markers, cells were treated with native LDL, low-oxLDL, or
hi-oxLDL (50 𝜇g/mL each) for 96 h and stained with PE-
conjugated anti-human CD86 antibodies. Flow cytometric
analysis was performed by a BD LSR II flow cytometer (BD
Bioscience).
2.5. Confocal Microscopy. THP-1 cells were cultured in 2-well
chambered cover glasses at 2 × 105 cells per well and treated
with native LDL, low-oxLDL, or hi-oxLDL (50 𝜇g/mL each)
for 96 h. Attached cells were stained with FITC-conjugated
anti-human mannose receptor (CD206) antibodies and ana-
lyzed using an FV1000 microscope (Olympus, Tokyo, Japan).
2.6. Isolation of Human Monocytes and Observation of Mor-
phological Changes. Bloodwas obtained fromhealthy donors
after acquiring internal review board approval and informed
consent (number 4-2012-0088). Peripheral blood mononu-
clear cells (PBMCs) were separated by Ficoll-Hypaque den-
sity gradient centrifugation (density = 1.077) at 1,600 rpm for
30min and human monocytes were purified from PBMCs
using Monocyte Isolation Kit II (Miltenyi Biotec, Bergsch
Gladbach, Germany). Staining for CD14 was performed to
confirmed monocyte population and usually >95% of cells
were positive. Humanmonocytes were cultured in RPMI1640
medium containing 10% FBS and penicillin-streptomycin
(100 units/mL and 100 𝜇g/mL, resp.) at 37∘C in a humidified
5% CO
2
incubator. Human monocytes were cultured in 12-
well plates at 2 × 105 cells per well and incubated with both
M-CSF (50 ng/mL) and hi-oxLDL or low-oxLDL (50𝜇g/mL
each) for 7 days. Morphological changes were observed using
bright-field microscope (IX71, Olympus, Tokyo, Japan).
2.7. Enzyme-Linked Immunosorbent Assay (ELISA). THP-1
cells were cultured at 2 × 105 cells per well in 12-well plates
and pretreated with native LDL, low-oxLDL, or hi-oxLDL
(50 𝜇g/mL each) for 24, 48, or 96 h.Themediumwas replaced
with fresh medium and then cells were stimulated with LPS
(100 ng/mL). Primary monocytes were cultured at 2 × 105
cells per well in 12-well plates and pretreated with both M-
CSF (50 ng/mL) and native LDL, low-oxLDL, or hi-oxLDL
(50 𝜇g/mL each) for 24, 48, or 72 h. Primary monocytes were
stimulated with LPS (20 ng/mL). Eighteen hours after LPS
stimulation, culture supernatants were harvested and stored
at−80∘C. ELISAwas performedwith a human cytokine TNF-
𝛼, IL-12p40, IL-6, and monocyte chemoattractant protein-1
(MCP-1) assay kit (BD Bioscience). The O.D. at 450 nm was
determined.
2.8. Western Blot. THP-1 cells were seeded at 2 × 105 cells per
well and treated with native LDL, low-oxLDL, or hi-oxLDL
(50 𝜇g/mL each). After 24 and 48 h, cells were harvested
and lysed with lysis buffer. After centrifugation, total protein
was stored at −80∘C. Each 50 𝜇g of protein samples was
loaded in 12% SDS-PAGE and transferred onto nitrocellulose
membrane (GE Healthcare, NJ, USA). Then, membranes
were reacted with anti-LOX-1 or anti-tubulin antibodies.
Protein bands were detected using a West Save Up western
blot detection kit (Ab frontier, Seoul, Korea).
2.9. Statistical Analysis. One-way ANOVA analysis was con-
ducted. 𝑝 < 0.05 was considered significant.
3. Results
3.1. Differential Effects of the LDL Oxidation Degree on
Granularity Induction and Proliferation of Monocytes. To
investigate the effects of the degree of LDL oxidation, we
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Figure 1: Effects of oxLDL on granularity, autofluorescence, and proliferation. THP-1 cells were treated with differentially oxidized LDL
(50 𝜇g/mL) for 24, 48, or 96 h. (a) Granularity and (b) autofluorescence were measured by flow cytometer. (c) Cell proliferation was assessed
byCCK-8 assay. Data representmeans± S.E. of three independent experiments. One-wayANOVAanalysis was used to determine significance
(∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001).
assessed differentiation and proliferation of THP-1 cells after
treatment with native LDL, low-oxLDL, or hi-oxLDL. Cell
granularity (Figure 1(a)) and autofluorescence (Figure 1(b))
were significantly increased in cells treated with hi-oxLDL
compared to cells treated with native LDL or low-oxLDL.
These effects by hi-oxLDL increased over time. After treat-
ment with hi-oxLDL, the cell proliferation rate did not
change compared to those of cells treated with native LDL.
However, cell proliferation was significantly decreased in
cells treated with low-oxLDL compared to that in cells
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Figure 2: Expression of CD86 and CD206 in response to oxLDL. THP-1 cells were treated with oxLDL (50 𝜇g/mL) for 96 h. (a) THP-1 cells
were stained with anti-CD86-PE antibodies and analyzed by flow cytometry. (b) THP-1 cells were stained with anti-CD206-FITC antibodies
and observed by confocal microscope (×200).
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Figure 3: Production of cytokines and chemokines in response to oxLDL. THP-1 cells were pretreated with differentially oxidized LDL
(50 𝜇g/mL) for 24, 48, or 96 h and treated with LPS (100 ng/mL) for 18 h. Culture supernatants were harvested and the levels of TNF-𝛼, IL-
12p40, IL-6, andMCP-1 were measured by ELISA. Data represent means ± S.E. of three independent experiments. One-way ANOVA analysis
was used to determine significance (∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001).
treated with hi-oxLDL (Figure 1(c)). These results indicate
that hi-oxLDL increases granularity and autofluorescence
whereas low-oxLDL decreases cell proliferation, suggesting
that monocytes respond differently to oxidation degree of
LDL.
3.2. Effect of OxLDL on the Expression of Surface Markers
of Macrophages. Next, we tested whether the degree of LDL
oxidation influences the differentiation of monocytes into
macrophages. When cells were treated with low-oxLDL,
the expression level of the marker for M1 macrophages,
CD86, was increased compared to that in cells treated
with hi-oxLDL (Figure 2(a)). In contrast, the expression
level of the marker for M2 macrophages, mannose receptor
(CD206), was significantly increased in cells treated with
hi-oxLDL compared to that in cells treated with native
LDL or low-oxLDL (Figure 2(b)). These results indicate that
the degree of LDL oxidation affects the differentiation of
monocytes into different subtypes of macrophages.
3.3. Effect of OxLDL on Cytokine Production. To assess cytok-
ine production, THP-1 cells were preexposed to differentially
oxidized LDL for 24, 48, or 96 h and then stimulated with
LPS. The production of TNF-𝛼 and IL-12p40 was decreased
in cells pretreated with hi-oxLDL compared to those in
cells pretreated with low-oxLDL (Figure 3(a)). However, the
production of IL-6 and MCP-1 was significantly increased in
cells pretreated with hi-oxLDL compared to cells pretreated
with low-oxLDL (Figure 3(b)). These results suggest that
macrophages secrete different sets of cytokines depending on
the oxidation level of LDL. More interestingly, low-oxLDL
and hi-oxLDL induced opposite cytokine profiles.
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Figure 4: Expression of LOX-1 in response to oxLDL. THP-1 cells were treated with differentially oxidized LDL (50𝜇g/mL) for 24 or 48 h.
Each 50 𝜇g of protein samples was loaded and analyzed with anti-LOX-1 antibodies and anti-tubulin antibodies (internal control).
3.4. Effects of OxLDL on LOX-1 Expression. OxLDL binds
to scavenger receptors, such as LOX-1, and also induces
the expression of LOX-1 in macrophages. We tested the
effect of oxLDL on the expression of LOX-1 in THP-1 cells.
LOX-1 expression increased in cells treated with hi-oxLDL
compared to cells treated with native LDL or low-oxLDL after
24 or 48 h (Figure 4).The expression of LOX-1was slightly but
not significantly decreased in cells treated with low-oxLDL
compared to that in cells treated with native LDL (Figure 4).
3.5. Effects of OxLDL onMorphological Changes and Cytokine
Production in Primary Monocytes. When human mono-
cytes were treated with low-oxLDL, cells have changed
into spindle-like shape, which is a unique feature of M1
macrophageswhereas the treatment of hi-oxLDL led to round
cells, which represents M2 macrophages (Figure 5(a)). The
production of TNF-𝛼 and IL-12p40 was decreased in mono-
cytes pretreated with hi-oxLDL compared to cells pretreated
with low-oxLDL (Figure 5(b)). Moreover, the production of
IL-6 and MCP-1 was significantly increased in monocytes
pretreatedwith hi-oxLDL (Figure 5(c)).These results support
that the oxidation degree of LDL affects primary monocytes
in a similar way to the monocytic cell line, THP-1 cells.
4. Discussion
During atherosclerotic plaque development, LDL can be
oxidized to various degrees by ROS or enzymes released by
macrophages in the subendothelial area [3]. This modified
LDL, along with growth factors such as M-CSF, affects
differentiation of monocytes into macrophages. Depending
on the extent and duration of oxidation, the physicochemical
properties of LDL, such as the charge, particle size, and
lipid content, are changed [12]. In addition, depending on
whether the lipid or protein component is oxidized, oxidized
LDL can induce different signaling pathways [13]. Our study
investigated the effects of differentially oxidized LDL on
the differentiation of macrophages. We used two types of
oxLDL, which were classified as low-oxLDL or hi-oxLDL
based on the TBAR value for lipid peroxidation and relative
electrophoretic mobility of LDL particles on agarose gels
[14, 15].
OxLDL is known to stimulate cell proliferation and
induces differentiation of monocytes and macrophages [16,
17]. Treatment of THP-1 cells with hi-oxLDL led to an
increase in cell granularity and autofluorescence, which is
a feature of differentiated macrophages [18]. Moreover, hi-
oxLDL did not change the cell proliferation rate compared
to native LDL. In contrast, in cells treated with low-oxLDL,
the granularity and autofluorescence were not increased and
cell proliferation was significantly decreased (Figure 1). Next,
as shown in Figures 2(a) and 2(b), CD86 (M1 macrophages)
was induced by low-oxLDL whereas mannose receptor (M2
macrophages) was induced by hi-oxLDL. The results of
the cytokine profiling showed an increased production of
TNF-𝛼 as well as IL-12p40 (Figure 3(a)), which reflects the
typical phenotype ofM1macrophages [19], whereas increased
production of IL-6 and MCP-1 (Figure 3(b)) reflects the M2
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Figure 5: Morphological changes and cytokine production in primary monocytes. (a) Human blood monocytes were isolated from PBMCs
and cultured with bothM-CSF (50 ng/mL) and differentially oxidized LDL (50𝜇g/mL each) for 7 days. Morphological changes were observed
using bright-field microscope (×200, 400). (b) Primary monocytes were pretreated with both M-CSF (50 ng/mL) and differentially oxidized
LDL (50 𝜇g/mL) for 24, 48, or 72 h and treated with LPS (20 ng/mL) for 18 h. Culture supernatants were harvested and the levels of TNF-𝛼,
IL-12p40, IL-6, and MCP-1 were measured by ELISA. Data represent means ± S.E. and one-way ANOVA analysis was used to determine
significance (∗𝑝 < 0.05, ∗∗𝑝 < 0.01, and ∗∗∗𝑝 < 0.001).
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Figure 6: Graphical summary of monocyte differentiation into M1 or M2 macrophages by differentially oxidized LDL.
macrophage phenotype. M2 macrophages can be further
classified into four subtypes, namely, M2a, M2b, M2c, and
M2d. Among them, M2b macrophages secrete high levels
of IL-6 and are referred to as “regulatory macrophages”
[10]. IL-6 is a pleiotropic cytokine that induces either proin-
flammatory or antiinflammatory responses and is involved
in a variety of conditions, such as obesity, arthritis, colitis,
and sepsis. Generally, IL-6 is considered a proinflammatory
cytokine, but its antiinflammatory roles have been suggested
in specific conditions [20]. Recent studies have shown that
IL-6 promotesM2 activationwhile attenuatingM1 activation.
When myeloid cells were primed with IL-6, the STAT3-IL-
4-STAT6 axis, which is a potent inducer of M2 polarization,
was activated, whereas when monocytes were pretreated
with IL-6, lipopolysaccharide-induced production of proin-
flammatory cytokines was attenuated [21]. Moreover, IL-6
induces the polarization of tumor-associated macrophages,
which are similar to obesity-associated M2 macrophages
[22]. These observations indicate that IL-6 plays a “counter-
inflammatory” role in controlling metabolic homeostasis in
low grade and chronic conditions, such as obesity.
MCP-1 plays an important role in the recruitment of
circulating monocytes to inflamed sites. MCP-1-mediated
recruitment of monocytes contributes to pathogenesis, but
several studies have shown thatMCP-1 has a beneficial role in
various inflammatory conditions. In the gut, lamina propria
macrophages, which revealed anM2-like phenotype, produce
large amounts of MCP-1. Additionally, a subset of lamina
propria macrophages are recruited in response to MCP-1 and
produce a large amount of IL-10 to maintain gut homeostasis
in the steady state as well as terminate excess inflammation
in the intestine [23]. Furthermore, MCP-1 exerts beneficial
effects in other inflammatory diseases such as ischemic heart
diseases by inhibiting the generation of ROS and by healing
necrotic areas in the myocardium [24, 25].
The exact roles of IL-6 and MCP-1 are still controversial.
However, previous studies on the anti-inflammatory effects of
IL-6 and MCP-1 support our results that hi-oxLDL-induced
differentiation of macrophages skews towards the M2-like
phenotype rather than the M1 phenotype (Figures 2(b) and
3(b)).
Our results show that hi-oxLDL induces IL-6 and MCP-1
production in macrophages, indicating that the expression of
these cytokines may be a feature of M2 macrophages. While
the interpretation of cytokine profilesmight be difficult, most
of our results for cytokine production and surface marker
expression suggest that low-oxLDL induces M1 polarization,
whereas hi-oxLDL leads to M2 polarization.
Next, we assessed the expression of LOX-1. LOX-1 is
a receptor for oxLDL and is expressed in a variety of
cells, such as endothelial cells, muscle cells, monocytes, and
macrophages [2, 26, 27]. After binding to oxLDL, LOX-1 is
internalized; this induces endoplasmic reticulum (ER) stress
that causes upregulation of LOX-1, which occurs via a positive
feedback loop between ER stress and LOX-1 expression and
macrophage differentiation into M2 macrophages together
with foam cell formation [27–29]. Figure 4 shows that treat-
ment with hi-oxLDL increased the LOX-1 expression of
macrophages. These high LOX-1 levels amplify the signals
fromhi-oxLDL and thus induce increased differentiation into
M2macrophages. A report usingmesenchymal stem cells has
demonstrated that treatments with oxLDLmarkedly increase
expressions of LOX-1 and MCP-1 [30], but in which the
oxidation degree of LDL was not clearly defined.
Lastly, we investigated the effects of differentially oxidized
LDL in primary monocytes. Our study showed primary
monocytes have changed into spindle shape after treatment
with low-oxLDL and into round cells after treatment with hi-
oxLDL. It is well known that the shape of M1 macrophages
adopt more spindle-like shape, whereas M2 macrophages
are more rounded [31, 32]. In addition to the morphological
changes, the cytokines profiles and the decreased production
of TNF-𝛼 and IL-12p40 as well as increased production of
IL-6 and MCP-1 after treatment with hi-oxLDL (Figure 5(b))
strongly support the role of differentially oxidized LDL in
monocyte differentiation to M1 or M2 macrophages.
Taken together, our results for granularity, autofluores-
cence, cytokine profiles, and surface makers suggest that
low-oxLDL induces macrophage polarization towards M1
phenotype whereas hi-oxLDL induces M2 phenotype. As
summarized in Figure 6, our results suggest that the degree of
oxidation of LDL is the important factor for differentiation of
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monocytes and macrophages and may determine the inflam-
mation status or even the development of atherosclerosis at
early stages of the disease.
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